12/16/2025
Our study, Safety and Efficacy of Magnetic Peripheral Nerve Stimulation for Treating Painful Diabetic Neuropathy, continues to be recognized in the peer-reviewed literature, including Neuromodulation: Technology at the Neural Interface.
“Magnetic peripheral nerve stimulation (mPNS) is the gateway Neuromodulation therapy that is noninvasive, cost-effective therapy not only for painful diabetic neuropathy (PDN) but also for post-traumatic and post-operative chronic neuropathic pain. The results rival those of spinal cord stimulation (SCS) for DPN without any complications reported in over 5,000 treatments.” — Marshall Bedder MD, Chief Medical Officer, Neuralace Medical
For clinicians treating painful diabetic neuropathy and chronic neuropathic pain, this publication adds meaningful long-term data to the evolving neuromodulation landscape.
Read the full peer-reviewed article: www.neuromodulationjournal.org/article/S1094-7159(25)00138-2/fulltext